Trulieve Cannabis Dividends and Buybacks
Dividend criteria checks 0/6
Trulieve Cannabis does not have a record of paying a dividend.
Key information
n/a
Dividend yield
1.1%
Buyback Yield
| Total Shareholder Yield | 1.1% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 47%?
Sep 04
Trulieve Cannabis Corp.'s (CSE:TRUL) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 15Trulieve Cannabis Corp.'s (CSE:TRUL) CEO Will Probably Struggle To See A Pay Rise This Year
Jun 06Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 38%?
May 01Revenues Not Telling The Story For Trulieve Cannabis Corp. (CSE:TRUL) After Shares Rise 26%
Mar 31Is Trulieve Cannabis (CSE:TRUL) A Risky Investment?
Feb 15There's Reason For Concern Over Trulieve Cannabis Corp.'s (CSE:TRUL) Massive 29% Price Jump
Jan 16Calculating The Intrinsic Value Of Trulieve Cannabis Corp. (CSE:TRUL)
Mar 06These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Extensively
Jan 26Does Trulieve Cannabis (CSE:TRUL) Have A Healthy Balance Sheet?
Aug 07Are Trulieve Cannabis Corp. (CSE:TRUL) Investors Paying Above The Intrinsic Value?
Jul 03These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Reasonably Well
Mar 21Is Trulieve Cannabis (CSE:TRUL) Using Too Much Debt?
Aug 16Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if TRUL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TRUL's dividend payments have been increasing.
Dividend Yield vs Market
| Trulieve Cannabis Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (TRUL) | n/a |
| Market Bottom 25% (CA) | 1.8% |
| Market Top 25% (CA) | 6.2% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (TRUL) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate TRUL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TRUL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate TRUL's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as TRUL has not reported any payouts.